McDonnell Boehnen Hulbert & Berghoff LLP partner Kevin Noonan, Ph.D. authors a DDN News article entitled, “A ray of hope in patenting “products of nature” perhaps?”. In a recent decision by the Federal Circuit, Roche Molecular Inc. v. Cepheid, the court raised for the first time a question regarding whether it may have over-interpreted the scope of the Supreme Court’s proscription regarding patenting compositions arising from products produced in nature in AMP v. Myriad Genetics. View the article